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There are numerous evidence-based wound debridement techniques that promote wound healing. However, some of these 
techniques may cause discomfort and pain for the patient and can be costly for the health care provider. A new, non-invasive 
wound debridement technique known as low-frequency ultrasonic debridement (LFUD) has been used for the removal of 
unhealthy tissue and bacterial load in wound management in the clinical setting. This paper reports the use of LFUD by a 
skin integrity clinical nurse consultant (CNC) as an adjuvant wound debridement and healing technique in a patient with a 
parastomal abscess. LFUD was found to benefit this patient in terms of expedited wound healing and increased comfort, enabling 
the patient to have a successful skin graft that led to complete wound closure and discharge from hospital in a timely manner.
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What this paper adds
LFUD is a new technique available to skin integrity clinicians 
that results in efficient wound bed preparation, promotes 
healing by stimulating the inflammatory process and healing 
cascade, whilst also having an antimicrobial effect. This 
treatment offers an alternative to surgical/sharp debridement 
and an adjunct to wound care and management and 
potentially results in reduced length of stay and increased 
patient comfort.
Introduction
Wound bed preparation is vital for wound healing. Studies 
have shown that wound healing is improved with correct 
wound bed preparation, which includes appropriate 
debridement, infection control and moisture management1-4. 
There are numerous debridement techniques available to 
remove devitalised, infected and/or necrotic tissue from 
the wound bed to promote wound healing. These include 
conservative and sharp wound debridement, autolytic, 
enzymatic, mechanical, chemical, biological or parasitic 
debridement and, more recently, low-frequency ultrasound 
debridement (LFUD). In the case study reported in this 
paper, LFUD technique was used to prepare the wound bed 
and aid in wound closure for a patient with a parastomal 
abscess. This new wound management initiative was a 
two-year project that commenced in October 2010 and was 
funded by the Department of Health, Victoria, Australia, 
in collaboration between the skin integrity and podiatry 
services in a metropolitan public hospital in Victoria.
Literature review
Research on conservative and sharp wound debridement, 
which involves the use of scalpel, scissors, or laser to cut 
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What is already known
Successful wound healing requires wound bed preparations 
and promotion of granulation and healing. Numerous 
techniques exist that aim to facilitate wound healing, with 
advantages and disadvantages for the patient and clinician 
already known.
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away dead tissue, has shown that all have advantages 
and disadvantages2,5. Sharp debridement is performed in 
an aseptic environment and is considered fast-acting and 
selective as it creates a blood-rich, clean wound surface in 
which granulating tissue can form6-8. However, as opposed 
to conservative debridement, it can be painful for the patient 
and costly, especially if an operating room is required5.
Autolytic debridement is achieved by using the body’s own 
enzymes via wound products such as transparent films, 
hydrogels and hydrocolloids that rehydrate and liquefy 
necrotic tissue, and is usually painless5. Research has shown 
that this method is effective for wound healing by removing 
black, necrotic tissue and slough, but is considered a slow 
process5-9, thus increasing the risk of infection5. Enzymatic 
debridement utilises plant enzymes and ureas to rapidly 
digest necrotic tissue proteins. However, the need for a medical 
prescription and secondary dressings make this an expensive 
option and the treatment may produce inflammation and/
or discomfort for the patient6. Mechanical debridement 
of necrotic tissue, which includes hydrotherapy, allows a 
dressing to proceed from moist to wet and then is manually 
removed to debride necrotic tissue7. As this technique is non-
selective, it may traumatise healthy or granulating healing 
tissue which may cause maceration or infection, and while it 
is relatively cheap, it can be time-consuming and painful5-8.
Chemical debridement is a technique that utilises bacteriocidal 
and bacteriostatic agents which can be cytotoxic to healthy 
granulation tissue and may be rendered inactive in a wound 
that contains blood or pus5-7. Studies have demonstrated that 
this method remains controversial as benefits need to be closely 
observed against any disadvantageous effects on wound 
healing9,10. Biological or parasitic debridement usually consists 
of sterile maggot larvae (Lucilia sericata) being introduced into 
a wound to secrete proteinase enzymes that help degrade 
necrotic tissue, digest bacteria and stimulate formation of 
granulation tissue5. While it is relatively cheap and fast, it can 
be painful and unpleasant, and is contraindicated in patients 
with life-threatening, deep-tracking wounds and bleeding 
abnormalities5,6,7,10,11. Other wound management therapies, 
such as negative pressure wound therapy (NPWT), can 
complement acute and chronic wound healing, with research 
supporting its effectiveness12. This therapy was used in 
conjunction with LFUD in this case study.
LFUD (Figure 1) is a relatively new technique used for wound 
debridement and to improve wound healing by perpetuating 
the wound healing cascade. LFUD was introduced to 
alleviate the pressure on operating rooms, decrease patient 
length of stay, enable debridement for patients who are 
unable to tolerate an anaesthetic, and facilitate follow-up 
and ongoing care in the community by a multidisciplinary 
team13,14. This technique removes unhealthy tissue, decreases 
bacterial load or bioburden, and is considered non-invasive 
because it uses ultrasound waves (frequencies >20,000 cycles 
per second) in much the same way as dentists remove 
plaque15. It has been reported that LFUD has numerous 
advantages, which include excellent wound bed preparation 
with antibacterial capabilities, minimal blood loss, improved 
patient safety and comfort, and cost savings due to decreased 
use of antibiotics, prevention of amputation and improved 
wound outcomes, particularly for patients who do not 
respond to standard wound care13-19. Compared to traditional 
conservative wound treatment, LFUD can expedite healing 
by removing impediments to healing whilst preserving a 
healthy, granulating wound bed that helps support successful 
skin closure via other surgical means such as skin grafting20.
LFUD technology has been used outside Australia for many 
years. Currently, there is no Australian published data on the 
use of LFUD13,14. International research has shown that most 
LFUD studies16-19 have included either patients with chronic 
leg or diabetic foot ulcers except one study15 that included 
patients with four large, non-healing surgical wounds which 
were debrided in preparation for skin closure via skin 
grafting. This study reported 107 LFUD treatments (range 
6–15) on 17 patients over eight months. The outcome was 
that 53% of patient wounds had complete healing, 35% had 
at least a 50% reduction in wound size, and 12% experienced 
a 20–30% reduction in wound size. After commencing LFUD 
treatments, no patients required antibiotic treatment.
The choice of wound debridement technique is dependent on 
the patient, availability of resources, the skill or qualification 
of the clinician, and cost. Each individual patient requires a 
considered assessment prior to the use of any debridement 
technique to ensure best practice for best patient outcomes.
LFUD procedure
The LFUD consists of a generator and a sonotrobe hand 
piece (Figure 2) attached to tubing connected to a sterile 
500-millilitre bag of normal saline. A foot pedal connected
to the generator is used to disperse the ultrasound to the
sonotrobe head. Debridement is achieved via normal saline
being streamed through the tubing to the sonotrobe head
with high-frequency ultrasound waves17 to create cavitation
or oscillating micro-gas bubbles of the saline18. The streaming,
steady mechanical forces applied to all exposed surfaces
disturbs the wound tissue where unhealthy tissue is washed
or suctioned away and healthy tissue is stretched and ‘tipped’ 
into an inflammatory process or healing cascade, ultimately
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Figure 1. LFUD Sonoca-185.
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debriding and healing at the same time13,18. Amplitude 
or speed of the ultrasound waves can be adjusted on the 
generator according to the patient’s tolerance, debridement 
and/or antibacterial needs13,17.
The period of debridement is calculated by the surface area 
of the wound divided by three, giving a minimum treatment 
time for antibacterial effect13. The clinician may choose to 
continue treatment over the estimated time to remove all 
visible unhealthy tissue depending on the patient’s tolerance. 
It is typical to initially treat the wound with a topical 
anaesthetic, such as Emla cream, to reduce sensitivity and 
improve patient tolerance. For example, neuropathic wounds 
may require no anaesthetic agents.
Considerations when using LFUD
There are three different styles of sonotrobe heads (Figure 
3) which can be used to debride the wound: hoof, double
ball and spatula. The hoof creates a shower head spray, the
spatula creates a one-directional spray and the double ball
creates a circular, multidirectional spray14. The clinician
makes the decision on which type of head to use based on
the type of wound. For example, a cavity wound requires
multidirectional spray; therefore the double ball would be
preferred. An undulated flat surfaced wound would require
a shower spray; therefore the hoof may be used. The spatula
head is useful for large, flat-surfaced wounds.
Infection control principles and personal protection measures 
are observed at all times when utilising the LFUD technique. 
Due to the potential spray associated with the LFUD technique, 
a one-metre clearance zone is maintained, shield mask and 
gown are highly recommended and appropriate wipe down 
of the clearance zone using recommended infection control 
wipes or detergents to prevent cross-infection is essential14.
The case study
The patient is a 66-year-old, married female living at home 
with her husband. She has a history of Crohn's disease, with 
a bowel resection in 1997 and colostomy formation in 2003, 
chronic obstructive pulmonary disease, cholecystectomy, 
anaemia, asthma and gastro-oesophageal reflux disease. In 
2008 she underwent a parastomal hernia repair with mesh, 
and a total hip replacement in July 2010, complicated by 
infection and requiring inpatient rehabilitation for almost 
two months. Whilst an inpatient at rehabilitation recovering 
from the hip surgery, she developed abdominal pain, nausea, 
vomiting and fever with an increased white cell count and 
pus in the colostomy site requiring readmission to the acute 
hospital.
Investigation revealed a fistula into the abdominal wall had 
developed with infection around the stoma site. A laparotomy 
was performed and the parastomal abscess was drained. Four 
days later, the abdominal mesh inserted during a previous 
hernia repair was removed and the stoma was re-sited.
On admission, her blood chemistry was within normal limits 
except an elevated white cell count and neutrophils. Her 
haemoglobin was slightly below accepted levels at 10.1 g/dL 
with total protein and calcium also below the recommended 
levels. The patient was considered to be within the healthy 
weight range for her age as assessed by a dietitian. Wound 
swabs showed small gram-positive and negative bacilli with 
a lot of degenerative cell debris. The patient’s medication 
regimen post-laparotomy is detailed in Table 1.
Negative pressure wound therapy (NPWT) was applied at all 
times in between LFUD debridement treatments at 80 mm/
Hg using sterile gauze as the medium of choice and changed 
twice weekly. The NPWT aided exudate management, 
increased the vascular supply and assisted with development 
of granulation tissue on the wound bed.
Rationale	for	LFUD
Surgical debridement was the first choice for this patient 
prior to the use of LFUD due to the complexity of the 
patient’s wound. NPWT had been used on the wound for less 
than four weeks and discussions were held with the covering 
general surgical team in regards to goals and outcomes 
for this patient. A skin integrity clinical nurse consultant 
(CNC) referral was made four weeks after the laparotomy 
and revision of stoma (Figure 4). This referral was made to 
expedite timely debridement for this patient as there were 
concerns over multiple and subsequent anaesthetics and 
Figure 2. Sonotrobes.
Figure 3. Sonotrobe heads – hoof, ball and spatula.
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delays in operating room bookings necessary for sharp 
wound debridement. The skin integrity CNC was given 
responsibility to care for this patient’s wound in consultation 
with the general surgical team.
Following patient consent, the initial LFUD treatment was 
of 48 minutes in duration due to the size of the wound and 
the amount of devitalised tissue. The hoof sonotrobe head 
was chosen for the directional spray. As the pain experienced 
by the patient was minimal, the amplitude was set to a 
maximum effect of 100% for debridement with the normal 
saline flow (lavage) set at 20%. The patient was given oral 
opiate pain relief of Oxycodone 5 mg. Concurrent suction was 
used to control any saline splash and general infection control 
principles were adhered to. Undermining of the bridge tissue 
was noted between the old stoma site and laparotomy site. 
Improvement was seen in the abdominal swelling (Figure 
5), periwound (surrounding skin) and overall skin integrity 
from first sighting, which was four weeks post-admission 
date. NPWT was used to continue to support granulation and 
management of exudate post-LFUD treatment.
The second treatment of LFUD was of 47 minutes' duration 
using the hoof and double ball sonotrobe head with concurrent 
suction. The hoof was used on the flat surfaces of the wound 
and the double ball head was used in the cavity and sinus 
areas that were exposed upon treatment. ‘Bridge’ tissue was 
necrotic and required extensive debridement. LFUD revealed 
a large proximal right sinus of 8 centimetres (cm). There was 
noted undermining of the right side of the wound by 2.5 cm 
(very close to the stoma) and a proximal undermining flap 
of 4 cm (Figure 6). For this treatment, the amplitude was 
decreased to 80% and the saline flow was increased to 40% 
due to the patient experiencing 7/10 pain in the sinus and 
cavity areas.Medline_JP_Advt_0912_Medline_JP_Advt_0912.qxd  3/09/12  10:48 AM  Page 1
Table 1. The case study patient’s medication regimen.
Medication Dose Route Frequency
Ceftriaxone 1 gm IV Daily
Metronidazole 500 mg IV Three times per day
Prednisolone 15 mg Orally Mane
Aspirin 100 mg Orally Mane
Enoxaparin sodium 20 mg Subcutaneous Daily
Frusemide 40 mg Orally or IV Mane
Humira 40 mg Subcutaneous Fortnightly
Oxycodone IR 5–10 mg Orally PRN four hourly
Oxycontin SR 5 mg Orally Twice per day
Ondansetron 4–8 mg Orally or IV Three times per day
Maxalon 10 mg Orally or IV Four times per day
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Figure 4. First view of wound post-laparotomy and revision of 
stoma.
Figure 5. Post first LFUD treatment of 48 minutes' duration.
Figure 6. Post second LFUD treatment of 47 minutes' duration.
Figure 7. Post third LFUD treatment of 35 minutes' duration. Wound 
size decreased by over 60%.
The third treatment of LFUD was of 35 minutes' duration. The 
right proximal wound depth decreased by 3 cm to measure 
5 cm in depth, the right side of wound of 2.5 cm depth was 
resolved (very close to the stoma) and the proximal flap 
remained 4 cm deep (Figure 7). The hoof sonotrobe head 
was used for the flat surfaces of the wound and the double 
ball sonotrobe head was used for the undermining cavity 
and sinus areas. Amplitude was adjusted to 100% with flow 
adjusted to 40% according to the patient’s tolerance and 
suction was simultaneously applied. The double ball revealed 
a 4 cm left distal tunnel. This section of wound treatment was 
limited due to the patient’s severe pain.
The final LFUD treatment was of 25 minutes' duration using 
the hoof sonotrobe head with amplitude of 80% and a flow 
of 25% that had been adjusted to the patient’s pain tolerance. 
Due to the lower flow rate, shorter treatment time duration 
and smaller wound size, suction was not required (Figure 8).
Outcomes
The patient's length of stay was 66 days with the four LFUD 
treatments occurring over a 10-day period. NPWT was 
continued for just under nine weeks. There was successful 
wound healing of over 60% within five days of commencing 
LFUD. Within another three days the wound size had 
decreased by almost another 50%. The patient returned to 
rehabilitation care and gained sufficient wound granulation 
tissue with maintenance NPWT to have the wound surgically 
grafted 12 days after the final LFUD treatment. Recovery was 
uneventful post-skin graft and the patient was discharged 
home.
Discussion
Whilst the LFUD technique was valuable for this patient’s 
wound management, the time taken to use this technique 
by the skin integrity CNC must be acknowledged. We 
recommend a combination of LFUD and conservative sharps 
wound debridement to manage such a large wound based 
on our experience in this case study. The conservative sharps 
wound debridement would remove the bulk of the obvious 
unhealthy tissue and allow the LFUD to remove the last 
of the unhealthy tissue without damaging the wound bed 
whilst still having the benefits of an antimicrobial effect and 
instigation of the healing cascade. Despite this, LFUD proved 
to be an optimal technique for wound debridement and 
wound bed preparation in conjunction with NPWT for this 
patient as the outcome was complete wound closure with 
skin graft and discharge home.
Conclusion
The use of LFUD as an adjunct in the healing or improving 
of chronic wounds was supported by this case study. The 
outcome for this patient with a parastomal abscess has been 
positive as complete wound closure was obtained. The LFUD 
achieved all the expected outcomes for this wound in that the 
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Figure 8. Post fourth LFUD treatment of 25 minutes' duration. 
Wound size decreased by almost another 50%.
wound bed preparation was acceptable for skin grafting by 
removing unhealthy tissue and bioburden, while controlling 
the patient’s level of discomfort and pain. The patient 
required minimal medication including anaesthetic agents 
and analgesics, and no intra-hospital transfer was required 
with cost benefits for the treating hospital. In addition, 
treatment time leading to health benefits for the patient was 
reduced. Given the wound care for this patient was led by the 
skin integrity CNC and the ability to utilise the LFUD in the 
clinical setting, there was the capacity to maintain a degree 
of flexibility with treatment times, thus allowing for other 
patient care needs.
Whilst LFUD is identified as an excellent modality for 
wound debridement, the need to continue embracing other 
well-known debridement techniques has not been ignored. 
Instead, LFUD is now considered to be another arsenal for 
skin integrity services and can be used as an adjunct in 
the debridement and antibacterial management of wounds. 
Further research to support the use of LFUD with and 
without NPWT and in combination with other methods of 
debridement is recommended.
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